FDA Approved Promacta for SAA
FDA has designated Promacta as a breakthrough therapy for treating people with SAA. Glaxo Smith Kline has received fast track status in the US for Promacta to treat SAA. I tried to attach a link but was unsuccessful. You can google: GlaxoSmithKline Drug Granted Breakthrough Therapy Designation to read one of several the articles on the topic.
|
Great news!! Thank you for sharing
|
Thanks for Sharing! :)
|
For other details see the Marrowforums news story about the FDA action.
|
All times are GMT -4. The time now is 07:01 AM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org